NuVasive receives FDA magnetic resonance conditional clearance for MAGEC — 5 insights

The FDA cleared magnetic resonance imaging for certain conditions on patients treated with NuVasive’s MAGEC system.

Advertisement

Here are five insights:

 

1. Since early onset scoliosis patients often require many MRIs, the lack of guidance on MR conditions served as a barrier to MAGEC adoption.

 

2. The FDA clearance encompasses MR conditions using a “1.5 Tesla Static Magnetic Field MRI machine at a maximum spatial field gradient of 3000 gauss/cm with a maximum MR System reported, whole body averaged specific absorption rate of 0.5 W/kg at 1.5T.”

 

3. The MAGEC system should not exceed a maximum temperature rise of more than 3.7 degrees Celsius after 15 minutes of continuous scanning.

 

4. MAGEC represents the sole FDA-cleared noninvasive solution for growth modulation in pediatric spinal deformity.

 

5. The MAGEC technology includes a single-use spinal rod that is surgically implanted to brace the spine during growth. Equipped with an internal magnet, surgeons may extend the rod via an external controller as the patient grows.

 

More articles on devices:
Stryker shares up 4.9% after exceeding earning expectations: 4 notes
DePuy Synthes, Mazor, NuVasive & more: 20 key notes — NASS edition
DePuy Synthes unveils Zero-Profile Plate for spinal fusions: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.